Yeah, there really is so much we don't know yet, especially how long the effect of the vaccine lasts and how it works in older people with weaker immune systems. I know Uruguay has reserved Pfizer for people 70+ because of lack of information about Sinovac in that age group. Here they initially said 60+ would get Pfizer for similar reasons. Four days later, they backtracked and started giving it to the elderly because there wasn't enough Pfizer coming in.

I remember at a press conference the Health Undersecretary was asked how long Sinovac's effects would last. She said they weren't sure but similar vaccines like the flu vaccine usually last about 4-6 months. What does that mean for the first people that were vaccinated here? I have seen some anecdotal reports of people who have gotten Sinovac doing antibody test having no or very few antibodies. Of course now I am wondering how common that is.


37% is terrible, but our Health Minister says it's good news and we are turning the corner. It is absolutely depressing. The last few days I have been in a mood over this because I don't know how we get out of this if the government refuses to take a look at what what they are doing and make changes. If the case increases in my area keep up as they have the last few days, we are headed to 500 active cases. That's with 51% of the target population being fully vaccinated and 75% having one dose.


There's an interesting article here:

Early adopters of Chinese vaccines see case surges; China plows ahead anyway | Ars Technica

Oh, and on the topic of quadrupling down on Sinovac, the Public Health Institute is looking for funding to carry out a longer term study. Why should we have to fund studies for the manufacturer? The tone of comments on the article is that the government is searching for any way it can to prove that the vaccine is great to not have to admit that Sinovac is the weakest vaccine out there. I wonder if the study will see the light of day if the results aren't good.